Expression and Clinical Significance of Latent Membrane Protein-1, Matrix Metalloproteinase-1 and Ets-1 Transcription Factor in Tunisian Nasopharyngeal Carcinoma Patients

Archives of Medical Research

Volumn 40, Issue 3, 2009, Pages 196-203

  Ben Nasr, Hela ^a   Chahed, Karim ^a,b   Remadi, Sami ^a,c   Zakhama, Abdelfettah ^a,d   Chouchane, Lotfi ^a,e  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c Laboratoire Cytopath   (Tunisia)

^d FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^e WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Ets 1; Immunohistochemistry; LMP 1; Metalloproteinases; Nasopharyngeal carcinoma

Indexed keywords

INTERSTITIAL COLLAGENASE; LATENT MEMBRANE PROTEIN 1; TRANSCRIPTION FACTOR ETS 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; ONSET AGE; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TUNISIA;

ADULT; CARCINOMA; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEIN C-ETS-1; TUMOR MARKERS, BIOLOGICAL; TUNISIA; VIRAL MATRIX PROTEINS;

EID: 67349134562     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.02.007     Document Type: Article

References (38)

1. Cammoun M., Hoerner V., and Mourali N. Tumors of the nasopharynx in Tunisia. An anatomic and clinical study based on 143 cases. Cancer 33 (1974) 184-192
2. Wei W.I., and Shum J.S.T. Nasopharyngeal carcinoma. Seminar 365 (2005) 2041-2054
3. Zheng H., Li L.L., Hu D.S., Deng X.Y., and Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 4 (2007) 185-196
4. Yoshizaki T., Horikawa T., Qing-Chun R., et al. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res 7 (2001) 1946-1951
5. Vockerodt M., Haier B., Buttgereit P., Tesch H., and Kube D. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway. Virology 280 (2001) 183-198
6. Wakisaka N., Kondo S., Yoshizaki T., Murono S., Furukawa M., and Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol 24 (2004) 5223-5234
7. Sheen T.S., Huang Y.T., Chang Y.L., et al. Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma. Jpn J Cancer Res 90 (1999) 1285-1292
8. Faqing T., Zhi H., Liqun Y., et al. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. Exp Oncol 27 (2005) 96-101
9. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89 (1997) 1260-1270
10. Yoshizaki T., Sato H., Furukawa M., and Pagano J.S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 95 (1998) 3621-3626
11. Horikawa T., Yoshizaki T., Sheen T.S., Lee S.Y., and Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89 (2000) 715-723
12. Lu J., Chua H.H., Chen S.Y., Chen J.Y., and Tsai C.H. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res 63 (2003) 256-262
13. Kim K.R., Yoshizaki T., Miyamori H., et al. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19 (2000) 1764-1771
14. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours (2005), IARC Press, Lyon
15. Chen C.L., Sheen T.S., Lou I.U., and Huang A.C. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma. Hum Pathol 32 (2001) 1240-1244
16. Ai M.D., Li L.L., Zhao X.R., Wu Y., Gong J.P., and Cao Y. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Cell Res 15 (2005) 777-784
17. Khabir A., Karray H., Rodriguez S., et al. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in North African nasopharyngeal carcinomas. Virol J 2 (2005) 39
18. Horikawa T., Sheen T.S., Takeshita H., Sato H., Furukawa M., and Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol 159 (2001) 27-33
19. Sarac S., Akyol M.U., Kanbur B., et al. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas. Am J Otolaryngol 22 (2001) 377-382
20. Fendri A., Khabir A., Hadhri-Guiga B., et al. Overexpression of COX-2 and LMP1 are correlated with lymph node in Tunisian NPC patients. Oral Oncol 44 (Jul 2008) 710-715
21. Lee D.C., Chua D.T., Wei W.I., Sham J.S., and Lau A.S. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma. Biomed Pharmacother 61 (2007) 520-526
22. Ben Nasr H., Mestiri S., Chahed K., et al. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin Chim Acta 384 (2007) 557-563
23. Kondo S., Wakisaka N., Schell M.J., et al. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer 115 (2005) 368-376
24. Zeng L., Guan X., and Tang F. Metastasis-associated gene in nasopharyngeal carcinoma by comparative genomic hybridization and cDNA array. Chin Soc Biochem Mol Biol 18 (2002) 588-593
25. Iwasaki C., Tanaka K., Abe M., and Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169 (1996) 522-531
26. Pande P., Mathur M., Shukla N.K., and Ralhan R. Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J Pathol 189 (1999) 40-45
27. Seth A., and Watson D.K. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41 (2005) 2462-2478
28. Stiller C.A. International variations in the incidence of childhood carcinomas. Cancer Epidemiol Biomarkers Prev 3 (1994) 305-310
29. Khabir A., Sellami A., Sakka M., et al. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 6 (2000) 3932-3936
30. Jalbout M., Hadj B., Jrad B., Bouaouina N., et al. Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int J Cancer 101 (2002) 146-150
31. Houali K., Wang X., Shimizu Y., et al. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res 13 (2007) 4993-5000
32. Braham H., Trimeche M., Ziadi S., et al. CD10 expression by fusiform stromal cells in nasopharyngeal carcinoma correlates with tumor progression. Virchows Arch 449 (2006) 220-224
33. Karray H., Ayadi W., Fki L., et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol 75 (2005) 593-602
34. Prince S., Keating S., Fielding C., Brennan P., Floettmann E., and Rowe M. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J Virol 77 (2003) 5000-5007
35. Daoud J., Toumi N., Bouaziz M., et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 39 (2003) 2349-2354
36. Murono S., Yoshizaki T., Sato H., Takeshita H., Furukawa M., and Pagano J.S. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res 60 (2000) 2555-2561
37. Bramhall S.R., Hallissey M.T., Whiting J., et al. Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial. Br J Cancer 86 (2002) 1864-1870
38. Lokeshwar B.L., Selzer M.G., Zhu B.Q., Block N.L., and Golub L.M. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int J Cancer 98 (2002) 297-309